See All Slides - tctmd.com

Slides

Presentation TCT 2013

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

Presenter: William O'Neill

October 31, 2013

Presentation TCT 2013

Case #4: OCT Case

Presenter: Kevin Croce

October 31, 2013

Presentation TCT 2013

Yes: Common Sense and Decades of Experience Rule This Discussion!

Presenter: Manesh Patel

October 31, 2013

Presentation TCT 2013

Transradial Access: If You Care About Bleeding and Survival!

Presenter: Thomas Tu

October 31, 2013

Presentation TCT 2013

Limus-Based Drug-Coated Balloon Platforms: Technological and Biological Challenges

Presenter: Sahil Parikh

October 31, 2013

Presentation TCT 2013

SAFE-PCI: Perspectives on Radial vs Femoral Access and Randomized in Registry Trials

Presenter: James Hermiller Jr

October 31, 2013

Presentation TCT 2013

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

Can Detection of Stable Coronary Plaque Composition by OCT, RF-IVUS, or NIR Spectroscopy Replace or Supplement Physiologic Lesion Assessment?

Presenter: Akiko Maehara

October 31, 2013

Presentation TCT 2013

Case Review: A Patient With Several Recent Complex PCIs Referred for Repeat Intervention: Managing Heavy Contrast and Radiation Exposure

Presenter: Stephen Balter

October 31, 2013

Presentation TCT 2013

Not Everyone with AS Should Get TAVR: Assessing Futility

Presenter: Nirat Beohar

October 31, 2013

Advertisement

Slides

A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary...

Case #4: OCT Case

Yes: Common Sense and Decades of Experience Rule This Discussion!

Transradial Access: If You Care About Bleeding and Survival!

Limus-Based Drug-Coated Balloon Platforms: Technological and Biological Challenges

SAFE-PCI: Perspectives on Radial vs Femoral Access and Randomized in Registry Trials

The Current US Guidelines Are Poorly Conceived! What Is Really Required to Be an Optimal TAVR Site?

Can Detection of Stable Coronary Plaque Composition by OCT, RF-IVUS, or NIR Spectroscopy Replace or Supplement Physiologic Lesion Assessment?

Case Review: A Patient With Several Recent Complex PCIs Referred for Repeat Intervention: Managing Heavy Contrast and Radiation Exposure

Not Everyone with AS Should Get TAVR: Assessing Futility

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content